Enhancement of rat islet tolerance with bone marrow transplantation using a non-myeloablative procedure II: Failure despite the presence of lymphocyte microchimerism in the fully allogeneic Lewis/Brown-Norway model

International Journal of Tissue Reactions

Volumn 26, Issue 3-4, 2004, Pages 75-83

  Kriz, Jan ^a   Saudek, F ^a   Girman, P ^a   Novota, P ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; STREPTOZOCIN; TACROLIMUS;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DONOR; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HYPERGLYCEMIA; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE CULTURE; MALE; MICROCHIMERISM; NONHUMAN; NONMYELOABLATIVE CONDITIONING; NUCLEOTIDE SEQUENCE; PANCREAS ISLET TRANSPLANTATION; POLYMERASE CHAIN REACTION; RAT; RECIPIENT; STREPTOZOCIN DIABETES; SURVIVAL RATE;

ANIMALS; BONE MARROW; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; IMMUNE TOLERANCE; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; RATS; RATS, INBRED BN; RATS, INBRED LEW;

ANIMALIA;

EID: 11344269942     PISSN: 02500868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ricordi C., Ildstad S.T, Demetris A.J., Abou el-Ezz A.Y, Murase N., Starzl T.E. Donor dendritic cell repopulation in recipients after rat-to-mouse bone marrow transplantation. Lancet, 339, 1610, 1992.
2. Starzl T.E., Demetris A.J., Trucco M., et al. Systemic chimerism in human female recipients of male livers. Lancet, 340 876, 1993.
3. Li H., Colson L.Y., Ildstad S.T. Mixed allogeneic chimerism achieved by lethal and non-lethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts. Transplantation, 60(6), 523, 1995.
4. Gammie J.S., Li S, Zeevi A, Demetris J.A, Ildstad S.T., Pham S.M. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts. Circulation, 98, 163, 1998.
5. Noris M., Azzollini N., Mister M., et al. Peripheral donor leukocytes prolong survival of rat renal allografts. Kidney Int., 56, 1101, 1999.
6. Suzuki K., Kazui T., Kawabe A., et al. Origin, occurrence, and function of microchimeric cells: V. Quantitative aspects of microchimerism following pancreaticoduodenal transplantation model in rats. Transplant. Proc., 30(7), 3849, 1998.
7. Bakonyi Neto A., Ricordi C., Feo C.F., at al. Correlation between allograft survival and chimeric state after bone marrow infusion in rat small bowel transplantation. Pediatr. Transplant., 3(1 , 67, 1999.
8. Tashiro H., Shintaku S., Fudaba Y., et al. Donor bone marrow perioperatively administered via portal vein induced prolongation of skin allograft survival and microchimerism in liver-transplanted rats Transplant. Proc., 32(7), 2363, 2000.
9. Pham M.S., Mitruka N.S., Youm W., et al. Mixed hematopoietic chimerism induces donor-specific tolerance for lung allografts in rodents. Am. J. Respir. Crit. Care Med., 159, 199, 1999.
10. Miller R.G., Muraoka S., Claesson M.H., Reimann J., Benviste P. The veto phenomenon in T-cell regulation. Ann. NY Acad. Sci., 532, 170, 1988.
11. Thomas J.M., Verbanac K.M., Carver F.M., Fasten-Jolly J., Haisch C.E., Gross U., Smith P.J. Veto cells in transplantation tolerance. Clin. Transplant., 8, 195, 1994.
12. Geppert T.D., Davis L.S., Gur H., Wacholz M.C., Lipsky P.E. Accessory cell signals involved in T cell activation. Immunol. Rev., 117, 5, 1990.
13. Li H., Ricordi C., Demetris A.J., et al. Mixed xenogeneic chimerism (mouse+rat → mouse) to induce donor-specific tolerance to sequential or simultaneous islets xenografts. Transplantation, 57 592, 1994.
14. Li H., Kaufman Ch.L., Ildstad S.T. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in non-obese diabetic mice. Surgery, 118, 192, 1995.
15. Sykes M., Sachs D.H. Mixed chimerism. Phil. Trans. Soc. Lond., B 356, 707, 2001.
16. Girman P., Saudek F., Kriz J. Enhancement of rat islet tolerance with bone marrow transplantation using a non-myeloablative procedure. Part I: Positive effect in a semi-allogeneic Lewis Brown-Norway to Brown-Norway rat transplant model. Int. J. Immunother., 20, 1, 2004.
17. Ricordi C., Murase N., Rastellini C., Behboo R., Demetris A.J., Starzl T.E. Indefinite survival of rat islet allografts following infusions of donor bone marrow without cytoablation. Cell Transplant., 5, 53, 1996.
18. Saudek F., Cihalova E., Karasova L., Kobylka P., Lomsky R. Increased glucagon-stimulated insulin secretion of cryopreserved rat islets transplanted into nude mice. J. Mol. Med., 77(1), 107, 1999.
19. Ikebukuro K., Adachi Y., Yamada Y., et al. Treatment of streptozocine-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein. Transplantation, 73, 512, 2002.
20. Stewart F.M., Crittenden R.B., Lowry P.A., Pearson-White S., Quesenberry P.J. Long-term engraftment of normal and post 5-fluorouracil murine marrow into normal nonmyeloblated mice. Blood, 81, 2566, 1993.
21. Brent L., Gowland G. Induction of tolerance of skin homografts in immunologically competent mice. Nature, 196, 1298, 1962.
22. Ricordi C., Karatzas G., Selvagi G., Neri J., Fernandez H., Tzakis A.G. Enhanced allograft acceptance by multiple infusions of donor bone marrow in humans. Transplant. Proc., 27, 3381, 1995.
23. Li Y., Zheng X.X., Li X.C., Zand M.S., Strom T.B. Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment. Transplantation, 66(10), 1387, 1998.
24. Hayakawa K., Hata M., Yanaihara H., Ohashi M., Ishikawa H., Tazaki H. Involvement of clonal deletion in immunotolerance induction: Tests of tacrolimus administration in rat renal transplantation. Transplant., Proc., 26(4), 1863, 1994.
25. Dahmen U., Qian S., Rao A.S., et al. Split tolerance induced by orthotopic liver transplantation in mice. Transplantation, 58(1), 1, 1994.